| Item Type | Name |
|
Concept
|
Exercise Test
|
|
Concept
|
Exercise Therapy
|
|
Concept
|
Exercise
|
|
Concept
|
Exercise Tolerance
|
|
Academic Article
|
Lack of arrhythmogenicity with ST-segment elevation during high-dose of dobutamine atropine stress in patients with documented or suspected coronary artery disease.
|
|
Academic Article
|
Comparison of effects of nisoldipine-extended release and amlodipine in patients with systemic hypertension and chronic stable angina pectoris.
|
|
Academic Article
|
Sildenafil citrate does not reduce exercise tolerance in men with erectile dysfunction and chronic stable angina.
|
|
Academic Article
|
Amlodipine: a once-daily calcium antagonist in the treatment of angina pectoris--a parallel dose-response, placebo-controlled study. The Amlodipine Study Group.
|
|
Academic Article
|
Assessment of "optimal" beta blockade in treating patients with angina pectoris.
|
|
Academic Article
|
Comparison of five beta-adrenoreceptor antagonists with different ancillary properties during sustained twice daily therapy in angina pectoris.
|
|
Academic Article
|
Ointments and transdermal nitroglycerin patches for stable angina pectoris.
|
|
Academic Article
|
Prognostic Value of 6-Minute Walk Distance in Patients Undergoing Percutaneous Coronary Intervention: a Veterans Affairs Prospective Study.
|
|
Academic Article
|
Effects of 8:00 a.m. and 2:00 p.m. doses of isosorbide-5-mononitrate during twice-daily therapy in stable angina pectoris.
|
|
Academic Article
|
Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance.
|
|
Academic Article
|
Interaction of indomethacin and nitroglycerin on hemodynamics and exercise tolerance in patients with angina pectoris.
|
|
Academic Article
|
Duration of effects of isradipine during twice daily therapy in angina pectoris.
|
|
Academic Article
|
Dose-response evaluation of once-daily therapy with a new formulation of diltiazem for stable angina pectoris. Diltiazem CD Study Group.
|
|
Academic Article
|
Double-blind efficacy and safety study of a novel anti-ischemic agent, ranolazine, versus placebo in patients with chronic stable angina pectoris. Ranolazine Study Group.
|
|
Academic Article
|
Hypertension and cardiovascular disease risk in women.
|
|
Academic Article
|
Influence of glyceryl trinitrate during supine and upright exercise in patients with angina pectoris.
|
|
Academic Article
|
Double-blind, dose-response, placebo-controlled multicenter study of nisoldipine. A new second-generation calcium channel blocker in angina pectoris.
|
|
Academic Article
|
Long-term bepridil monotherapy for angina pectoris.
|
|
Academic Article
|
Mechanisms of myocardial ischemia induced by epinephrine: comparison with exercise-induced ischemia.
|
|
Academic Article
|
Nitrates as an integral part of optimal medical therapy and cardiac rehabilitation for stable angina: review of current concepts and therapeutics.
|
|
Academic Article
|
Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy.
|
|
Academic Article
|
Usefulness of twice-daily isosorbide-5-mononitrate in preventing development of tolerance in angina pectoris.
|
|
Academic Article
|
Hemodynamic effects of disopyramide at rest and during exercise in normal subjects.
|
|
Academic Article
|
Effects of low and high glucose in a glucose-insulin-potassium infusion on hemodynamics and exercise tolerance in patients with angina pectoris.
|
|
Academic Article
|
Are the clinical and hemodynamic events during exercise stress testing in invasive studies in patients with angina pectoris reproducible?
|
|
Academic Article
|
Propranolol in angina pectoris: comparison of therapy given two and four times daily.
|
|
Academic Article
|
Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy.
|
|
Academic Article
|
Additional antianginal and anti-ischemic efficacy of mibefradil in patients pretreated with a beta blocker for chronic stable angina pectoris.
|
|
Academic Article
|
The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease.
|
|
Academic Article
|
Safety of symptom-limited cardiopulmonary exercise testing in patients with chronic heart failure due to severe left ventricular systolic dysfunction.
|
|
Academic Article
|
Exercise performance, physical activity, and health-related quality of life in participants with stable angina.
|
|
Academic Article
|
A randomized, double-blind, placebo-controlled, crossover, dose-ranging multicenter study to determine the effect of sublingual nitroglycerin spray on exercise capacity in patients with chronic stable angina.
|
|
Academic Article
|
Anemia and associated clinical outcomes in patients with heart failure due to reduced left ventricular systolic function.
|
|
Academic Article
|
Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration.
|
|
Academic Article
|
Effects of glucose-insulin-potassium infusion on the angina response during treadmill exercise.
|
|
Academic Article
|
Reproducibility of clinical and hemodynamic parameters during pacing stress testing in patients with angina pectoris.
|
|
Academic Article
|
Cardiac performance at rest and during exercise in normal subjects.
|
|
Academic Article
|
Comparison of the immediate effects of five beta-adrenoreceptor-blocking drugs with different ancillary properties in angina pectoris.
|
|
Academic Article
|
Hemodynamics at rest and during supine and sitting bicycle exercise in normal subjects.
|
|
Academic Article
|
Propranolol in the treatment of angina pectoris. Comparison of duration of action in acute and sustained oral therapy.
|
|
Academic Article
|
Hemodynamics at rest and during supine and sitting bicycle exercise in patients with coronary artery disease.
|
|
Academic Article
|
Amlodipine--a once-daily calcium antagonist in the treatment of angina pectoris: a parallel dose-response placebo-controlled study.
|
|
Academic Article
|
Rupture of abdominal aortic aneurysm during exercise. Gated blood pool studies.
|
|
Academic Article
|
Duration of effects and tolerance of slow-release isosorbide-5-mononitrate for angina pectoris.
|
|
Academic Article
|
Comparative efficacy of 200, 300 and 400 mg of bepridil for chronic stable angina pectoris.
|
|
Academic Article
|
Proceedings: Left ventricular pressure-volume changes during exercise-induced pain in patients with angina pectoris.
|
|
Academic Article
|
Effects of zatebradine (ULFS 49 CL), a sinus node inhibitor, on heart rate and exercise duration in chronic stable angina pectoris. Zatebradine Investigators.
|